top of page
  • Writer's pictureKBM

USP Considerations During Pandemic

On 11 April 2020, the United States Pharmacopeia (USP) issued guidance regarding operational considerations during the COVID-19 pandemic. These instructions include assignment of beyond use dates, certifications, and cleaning/disinfecting. The Joint Commission (TJC) has issued declared that "(o)rganizations may utilize these guidelines and remain in compliance with Joint Commission standards until the state of emergency has been lifted at the regional, state or national level."

5 views0 comments

Recent Posts

See All

Have You Evaluated Your Patient Care Contracts?

This article begins to highlight the need for effective contract performance documentation and evaluation. You must place specific, measurable, attainable, relevant, and timely (SMART) key performanc


Post: Blog2_Post
bottom of page